We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Asthma in the Elderly: The Role of Vitamin D

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01730976
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : September 10, 2014
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
We will study whether taking vitamin D improves asthma control and spirometric values in elderly asthmatics.

Condition or disease Intervention/treatment Phase
Asthma in the Elderly Dietary Supplement: Vitamin D 2,000 I.U. Phase 3

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Asthma in the Elderly: The Role of Vitamin D
Study Start Date : November 2012
Primary Completion Date : March 2013
Study Completion Date : March 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma Vitamin D
Drug Information available for: Vitamin D
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Vitamin D 2,000 I.U. daily
Study subjects will take 2,000 I.U. vitamin D daily for three months
Dietary Supplement: Vitamin D 2,000 I.U.
Other Name: Vitamin Shoppe


Outcome Measures

Primary Outcome Measures :
  1. Improvement in Asthma Control Test (ACT) score [ Time Frame: Three months ]

Secondary Outcome Measures :
  1. Improvement in pulmonary function tests values (FEV1%, etc.) [ Time Frame: Three months ]

Other Outcome Measures:
  1. Serum vitamin D and calcium levels [ Time Frame: Three months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Asthma, age of 65 years old or older

Exclusion Criteria:

  • Current smokers, subjects who smoked more than 10 pack/year, subjects taking digoxin, subjects with liver disease
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01730976


Locations
United States, Pennsylvania
Rohr and Columbo Asthma, Allergy and Immunology Specialists
Bryn Mawr, Pennsylvania, United States, 19010
Sponsors and Collaborators
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Investigators
Principal Investigator: Michele Columbo, M.D. Rohr and Columbo Associates
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Michele Columbo, M.D., Principal Investigator, Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
ClinicalTrials.gov Identifier: NCT01730976     History of Changes
Other Study ID Numbers: F/N-R13-3217B
SSRF2012-01 ( Other Grant/Funding Number: SSRF2012-01 )
First Posted: November 21, 2012    Key Record Dates
Last Update Posted: September 10, 2014
Last Verified: September 2014

Keywords provided by Michele Columbo, M.D., Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.:
asthma, elderly, vitamin D

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Vitamins
Vitamin D
Ergocalciferols
Micronutrients
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents